Pentraxins and Atherosclerosis: The Role of PTX3
Keywords: Astragalus bisculatus; Balkan Endemic Nephropathy; Bioavailability; Bronchial asthma; Coumarin; Kashin-Beck Syndrome; Keshan Disease (KD); Lymphedema; Nephropathy; PTX3; Pentraxin; Phleum pratense L; Prepartum supplementation; Se cruciferae; Se-cysteine; Se-dependent deiodinases; Se-methionine; Selenomax; Selenomethionine (Semet); Selenoprotein P; White Muscle Disease (WMD); antagonism; atherosclerosis; bio-fortification; flavon-oids; forages; glutathione peroxidase; goiter; inflammation; innate immunity; iodine deiodinase; leek (Allium porrum); methylselenocysteine (SeMCYS); myo-degenerative syndrome; pedogenesis; red clover (Trifolium pratense L; ryegrass; selenifer-ous regions; seleniferous soils; selenoproteins; selenotrisulfide; sesquioxides; severe sepsis; sulfur fertilization; tocopherol; unthriftyness; urinary tract tumors; vascular pathology
Document Type: Research Article
Publication date: 01 January 2011
- Current Pharmaceutical Design publishes timely in-depth reviews covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area. A Guest Editor who is an acknowledged authority in a therapeutic field has solicits for each issue comprehensive and timely reviews from leading researchers in the pharmaceutical industry and academia.
Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design, including: medicinal chemistry, pharmacology, drug targets and disease mechanism. - Editorial Board
- Information for Authors
- Subscribe to this Title
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content